发明名称 |
NOVEL HUMAN ENDOGENOUS RETORVIRAL ERV3 VARIANT AND USES THEREOF FOR DIAGNOSING OVARIAN CANCER |
摘要 |
The present invention relates to polynucleotide and polypeptide sequences of a novel human endogenous retroviral ERV3 variant which is differentially expressed in ovarian cancer cells when compared to normal cells. The present invention more particularly relates to the use of these polynucleotide and polypeptide in the diagnosis, prognosis or treatment of cancer and in the detection of cancer cells.
|
申请公布号 |
CA2745849(A1) |
申请公布日期 |
2010.06.17 |
申请号 |
CA20082745849 |
申请日期 |
2008.12.23 |
申请人 |
ALETHIA BIOTHERAPEUTICS INC. |
发明人 |
TREMBLAY, GILLES BERNARD;MORAITIS, ANNA;FILION, MARIO |
分类号 |
C12N15/12;A61K31/7088;A61K38/08;A61K38/10;A61K38/17;A61K39/395;A61K48/00;A61P35/00;C07K14/15;C07K14/47;C07K14/705;C07K16/18;C12N15/11;C12N15/13;C12Q1/68;G01N33/574 |
主分类号 |
C12N15/12 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|